57 completed, 3 unknown, 2 terminated, 1 recruiting. 43 Phase 3, 11 Phase 4, 7 Phase 2, 2 Phase 1, 1 Not applicable.
Follow ciclesonide: new trials by email Literature Review of ciclesonide trials Research Report on ciclesonide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inhaled Ciclesonide Study in Preterm Infants Alvesco Inhalant Product - Bronchopulmonary Dysplasia | Phase 1 | Recruiting | Venkatesh Sampath | 30 | 2025-09-16 | 2026-09-09 |
| Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma Tapering of inhaled corticosteroid (ICS) treatment - Asthma | Phase 4 | Completed | Hvidovre University Hospital | 20 | 2022-06-01 | 2025-03-17 |
| PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V Niclosamide, Placebo, Ciclesonide - Covid19 | Phase 2 / Phase 3 | Completed | Cambridge University Hospitals NHS Foundation Trust | 2240 | 2021-02-19 | 2025-06-20 |
| Inhaled Ciclesonide for Outpatients With COVID19 Normal Saline intranasal and placebo inhaler, Ciclesonide, Ciclesonide nasal - COVID 19 | Phase 2 / Phase 3 | Terminated | McGill University Health Centre/Research Institute of the McGill University Health Centre | 215 | 2020-09-15 | 2022-06-10 |
| Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation Vitamins, Telmisartan, Ciclesonide - Corona Virus Infection, Sars-CoV2 | Phase 2 / Phase 3 | Completed | University Hospital, Bordeaux | 412 | 2020-07-29 | 2026-05-12 |
| A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients Ciclesonide, Placebo - COVID-19 | Phase 3 | Completed | Covis Pharma S.à.r.l. | 400 | 2020-06-08 | 2023-02-09 |
| Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) Ciclesonide Inhalation Aerosol - Covid-19, Pneumonia, Viral | Phase 2 | Unknown | Ola Blennow, MD, PhD | 98 | 2020-05-29 | 2022-02-02 |
| A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19 Ciclesonide Metered Dose Inhaler [Alvesco] - COVID-19 | Phase 2 | Completed | Korea University Guro Hospital | 68 | 2020-04-01 | 2021-06-24 |
| Ciclesonide vs Fluticasone Nasal Sprays in Nasal Poplyposis Ciclesonide, Fluticasone - Chronic Rhinosinustis With Polyps | Phase 3 | Unknown | Tehran University of Medical Sciences | 32 | 2016-01-01 | 2016-01-28 |
| Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia Ciclesonide, Ciclesonide Placebo - Seasonal Allergic Rhinitis | Phase 3 | Completed | AstraZeneca | 80 | 2014-08-01 | 2017-02-02 |
| A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR) ciclesonide nasal aerosol, ciclesonide nasal spray - Perennial Allergic Rhinitis | Phase 4 | Completed | Sumitomo Pharma America, Inc. | 737 | 2012-09-01 | 2014-07-24 |
| Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase, QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo - Asthma, Allergic Rhinitis | Phase 4 | Completed | West Penn Allegheny Health System | 22 | 2012-03-01 | 2020-11-04 |
| Effect of High Dose Ciclesonide on Asthma Control Ciclesonide - Bronchial Asthma | Phase 3 | Completed | AstraZeneca | 520 | 2011-11-01 | 2017-02-10 |
| Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray ciclesonide, mometasone - Perennial Allergic Rhinitis | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 327 | 2011-07-01 | 2013-04-30 |
| Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma Vitamin D3, Ciclesonide - Asthma | Phase 3 | Completed | Milton S. Hershey Medical Center | 408 | 2011-04-01 | 2014-08-13 |
| Omnaris Versus Levocetirizine Phase 4 Study Ciclesonide, Levocetirizine, Ciclesonide & Levocetirizine - Allergic Rhinitis | Phase 4 | Completed | Handok Inc. | 349 | 2011-01-01 | 2012-09-06 |
| Cost-effectiveness Study of Beclomethasone Versus Ciclesonide as Controller Medications in Pediatric Asthma Beclomethasone, Ciclesonide - Asthma | Phase 4 | Completed | Grünenthal Colombiana S.A. | 94 | 2010-07-01 | 2011-04-12 |
| ATEM (Alvesco Non-interventional Study) Alvesco - Asthma, Allergy | Completed | AstraZeneca | 400 | 2010-03-01 | 2016-12-05 | |
| Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis Ciclesonide HFA Nasal Aerosol 320 mcg, Ciclesonide HFA Nasal Aerosol 160 mcg, HFA Nasal Aerosol placebo - Perennial Allergic Rhinitis | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 310 | 2010-01-01 | 2012-07-19 |
| Small Particle Steroids in Refractory Asthma Ciclesonide, Placebo - Asthma | Phase 4 | Completed | University of Nottingham | 30 | 2010-01-01 | 2014-01-31 |
Showing 20 of 63. Sign in to see all of them.
Asthma (38) · Rhinitis, Allergic, Perennial (9) · Rhinitis, Allergic, Seasonal (9) · Rhinitis, Allergic (7) · COVID-19 (5) · Hypersensitivity (4) · Coronavirus Infections (2) · Respiratory Hypersensitivity (2) · Respiratory Tract Diseases (2) · Bronchopulmonary Dysplasia (1) · Disease (1) · Glomerulonephritis (1) · Lung Diseases (1) · Lupus Erythematosus, Systemic (1) · Nasal Polyps (1)
AstraZeneca (34) · Sanofi (4) · Sumitomo Pharma America, Inc. (4) · Covis Pharma S.à.r.l. (2) · Allergy & Asthma Medical Group & Research Center (1) · Boehringer Ingelheim (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Cantonal Hospital, Baselland (1) · Grünenthal Colombiana S.A. (1) · Hamilton Health Sciences Corporation (1) · Handok Inc. (1) · Hvidovre University Hospital (1) · Korea University Guro Hospital (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Medical University of Lodz (1)
United States (20) · Canada (11) · Germany (8) · Hungary (8) · Poland (8) · South Africa (8) · France (5) · Russia (5) · Brazil (4) · Netherlands (4) · Spain (4) · United Kingdom (4) · India (3) · South Korea (3) · Switzerland (3)
Agnieszka Brzozowska, MD, PhD (1) · Anne Fitzpatrick, MD (1) · Christine Sorkness, MD (1) · Craig LaForce, MD (1) · Daniel P Andersson, MD, PhD (1) · David T. Mauger, PhD (1) · Deborah A Gentile, MD (1) · Eli O Meltzer, MD (1) · Elizabeth Bade, MD (1) · Elliot Israel, MD (1) · Francisco Hinestrosa, MD,MSc (1) · Homer Boushey, MD (1)
PMID 32738928, PMID 33388170, PMID 18070931, PMID 18071011, PMID 18287130, PMID 19085579, PMID 19412327, PMID 19549431, PMID 19549432, PMID 20110036, PMID 20595155, PMID 20619624, PMID 21088114, PMID 21130386, PMID 21839625, PMID 24169063, PMID 24838406, PMID 25858909, PMID 26971692, PMID 33050924, PMID 34441840, PMID 34473343, PMID 34728476, PMID 34807241, PMID 36813503, PMID 36915199, PMID 37794472, PMID 38454482, PMID 39934669, PMID 41656183
R21HD116421 (1), U10HL098115 (1)